BioCentury | Nov 17, 2003
Company News

Kourion Therapeutics AG, ViaCell deal

...Cell therapy company ViaCell acquired stem cell company Kourion. ViaCell said the acquisition provides preclinical candidates...
...in cardiac repair and orthopedic indications, plus related IP. ViaCell also said it will use Kourion's...
...and other European countries. Kourion CEO Stephan Wnendt will become SVP of ViaCell European Operations. Kourion...
BioCentury | Nov 12, 2003
Company News

ViaCell acquires Kourion

...Cell therapy company ViaCell (Boston, Mass.) acquired stem cell company Kourion Therapeutics (Langenfeld, Germany). ViaCell said...
...in cardiac repair and orthopedic indications, plus related IP. ViaCell also said it will use Kourion's...
...banking to establish ViaCell's Viacord cord blood banking service in Germany and other European countries. Kourion...
BioCentury | Jun 3, 2002
Company News

Kourion Therapeutics AG management update

Kourion Therapeutics AG , Duesseldorf, Germany Business: Gene/Cell therapy Hired: Jurgen Peter as CFO, formerly equity investment manager at Deutsche Bank AG's Deutsche Beteiligungsgesellschaft subsidiary; and Christian van den Bos as VP of development and operations,...
BioCentury | Dec 24, 2001
Company News

Kourion scientific advisory board update

Kourion Therapeutics GmbH , Duesseldorf, Germany Business: Gene/Cell therapy, Biomaterial/Skin/Wound Appointed: Arnold Caplan, professor of biology at Case Western Reserve University WIR Staff Dermatology...
BioCentury | Dec 24, 2001
Company News

Kourion, Case Western Reserve University deal

...potential of Kourion's cord blood-derived somatic stem cells for use in healing complicated bone fractures. Kourion Therapeutics GmbH...
Items per page:
1 - 5 of 5
BioCentury | Nov 17, 2003
Company News

Kourion Therapeutics AG, ViaCell deal

...Cell therapy company ViaCell acquired stem cell company Kourion. ViaCell said the acquisition provides preclinical candidates...
...in cardiac repair and orthopedic indications, plus related IP. ViaCell also said it will use Kourion's...
...and other European countries. Kourion CEO Stephan Wnendt will become SVP of ViaCell European Operations. Kourion...
BioCentury | Nov 12, 2003
Company News

ViaCell acquires Kourion

...Cell therapy company ViaCell (Boston, Mass.) acquired stem cell company Kourion Therapeutics (Langenfeld, Germany). ViaCell said...
...in cardiac repair and orthopedic indications, plus related IP. ViaCell also said it will use Kourion's...
...banking to establish ViaCell's Viacord cord blood banking service in Germany and other European countries. Kourion...
BioCentury | Jun 3, 2002
Company News

Kourion Therapeutics AG management update

Kourion Therapeutics AG , Duesseldorf, Germany Business: Gene/Cell therapy Hired: Jurgen Peter as CFO, formerly equity investment manager at Deutsche Bank AG's Deutsche Beteiligungsgesellschaft subsidiary; and Christian van den Bos as VP of development and operations,...
BioCentury | Dec 24, 2001
Company News

Kourion scientific advisory board update

Kourion Therapeutics GmbH , Duesseldorf, Germany Business: Gene/Cell therapy, Biomaterial/Skin/Wound Appointed: Arnold Caplan, professor of biology at Case Western Reserve University WIR Staff Dermatology...
BioCentury | Dec 24, 2001
Company News

Kourion, Case Western Reserve University deal

...potential of Kourion's cord blood-derived somatic stem cells for use in healing complicated bone fractures. Kourion Therapeutics GmbH...
Items per page:
1 - 5 of 5